Status | Study |
Recruiting |
Study Name: Vestibular Schwannoma - Radiosurgery or Expectation: V-REX. Condition: Vestibular Schwannoma Date: 2014-09-23 Interventions: Radiation: gamma knife radiosurgery Leksell Perfection model gamma knife. |
Recruiting |
Study Name: Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas Condition: Neurofibromatosis Type 2 Vestibular Schwannomas Date: 2014-04-29 Interventions: Drug: Axitinib Other Name: Inlyta |
Completed |
Study Name: Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma Condition: Schwannoma Neurinoma Date: 2013-09-15 |
Recruiting |
Study Name: Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study Condition: Vestibular Schwannoma Date: 2013-09-05 Interventions: Radiation: Initial Gamma knife radiosurgery |
Recruiting |
Study Name: Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas Condition: Neurofibromatosis Type 2 Vestibular Schwannomas Date: 2013-06-11 Interventions: Drug: RAD001 Other Name: Everolimus |
Active, not recruiting |
Study Name: Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Condition: Neurofibromatosis Type 2 Progressive Vestibular Schwannomas Date: 2013-01-07 Interventions: Drug: Bevacizumab Treatment will be administered on an out |
Completed |
Study Name: Vestibular Schwannoma and Psychological Factors Condition: Vestibular Schwannoma Date: 2012-09-28 |
Completed |
Study Name: Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients Condition: Neurofibromatosis 2 Date: 2011-11-30 Interventions: Drug: RAD001 10 mg per os / day or 05mg per os / day with 12 month |
Recruiting |
Study Name: Stereotactic Radiation in Vestibular Schwannoma Condition: Vestibular Schwannoma Date: 2011-10-02 Interventions: Radiation: stereotactic radiotherapy |
Recruiting |
Study Name: Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma Condition: Neurofibromatosis Type 2 Neuroma, Acoustic Date: 2011-04-21 Interventions: Drug: RAD001, everolimus Adults: 10 mg p.o. daily dose, age 16 - 17: 3.0 mg/m2 p.o. daily |